These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 97359)
1. Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315. Sonenshein GE; Siekevitz M; Siebert GR; Gefter ML J Exp Med; 1978 Jul; 148(1):301-12. PubMed ID: 97359 [TBL] [Abstract][Full Text] [Related]
2. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor. Roman S; Moore JS; Darby C; Müller S; Hoover RG J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498 [TBL] [Abstract][Full Text] [Related]
3. Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability. Mosmann T; Baumal R J Immunol; 1975 Oct; 115(4):955-62. PubMed ID: 809509 [TBL] [Abstract][Full Text] [Related]
4. Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells. Hozumi N; Wu G; Murialdo H; Baumal R; Mosmann T; Winberry L; Marks A J Immunol; 1982 Jul; 129(1):260-6. PubMed ID: 6806362 [TBL] [Abstract][Full Text] [Related]
5. Overproduction of immunoglobulin mRNA by a murine myeloma MOPC 315 variant cell line. Ponte PA; Dean M; Pepe VH; Sonenshein GE J Immunol; 1984 Jul; 133(1):476-81. PubMed ID: 6427346 [TBL] [Abstract][Full Text] [Related]
6. Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Green M; Graves PN; Zehavi-Willner T; McInnes J; Pestka S Proc Natl Acad Sci U S A; 1975 Jan; 72(1):224-8. PubMed ID: 804169 [TBL] [Abstract][Full Text] [Related]
7. Multiple expression of Ig lambda-chain encoding RNA species in murine plasmacytoma cells. Schwartz RC; Sonenshein GE; Bothwell A; Gefter ML J Immunol; 1981 Jun; 126(6):2104-8. PubMed ID: 6164720 [TBL] [Abstract][Full Text] [Related]
8. Regulation of immunoglobulin biosynthesis in the murine plasmacytoma MOPC 315. Siebert GR; Harris JF; Gefter ML J Immunol; 1978 Nov; 121(5):1808-18. PubMed ID: 101592 [TBL] [Abstract][Full Text] [Related]
9. In vivo growth advantage of the MOPC-315 mouse myeloma over its immunoselected variants. Hannestad K; Kao MS; Lynch RG; Eisen HN J Natl Cancer Inst; 1977 Oct; 59(4):1307-10. PubMed ID: 409851 [TBL] [Abstract][Full Text] [Related]
10. RNA sequences homologous to the 3' portion of immunoglobulin alpha-chain mRNA in thymus-derived lymphocytes. Near RI; Storb U Biochemistry; 1979 Mar; 18(6):964-72. PubMed ID: 106877 [No Abstract] [Full Text] [Related]
11. Molecular characterization of a nonsecreting myeloma mutant. Argon Y; Burrone OR; Milstein C Eur J Immunol; 1983 Apr; 13(4):301-5. PubMed ID: 6406235 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains. Adams JM; Gough NM; Webb EA; Tyler BM; Jackson J; Cory S Biochemistry; 1980 Jun; 19(12):2711-9. PubMed ID: 6249338 [No Abstract] [Full Text] [Related]
13. Idiotype-specific T cell suppression of light chain mRNA expression in MOPC-315 cells is accompanied by a posttranscriptional inhibition of heavy chain expression. Milburn GL; Parslow TG; Goldenberg C; Granner DK; Lynch RG J Mol Cell Immunol; 1984; 1(2):115-23. PubMed ID: 6242851 [TBL] [Abstract][Full Text] [Related]
14. The regulation of membrane-bound and secreted alpha-chain biosynthesis during the differentiation of the B cell lymphoma I.29. Sitia R; Rubartelli A; Kikutani H; Hammerling U; Stavnezer J J Immunol; 1985 Oct; 135(4):2859-64. PubMed ID: 3928759 [TBL] [Abstract][Full Text] [Related]
15. Suppressor T cell action inhibits the expression of an excluded immunoglobulin gene. Parslow TG; Milburn GL; Lynch RG; Granner DK Science; 1983 Jun; 220(4604):1389-91. PubMed ID: 6222474 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin biosynthesis by the MOPC 173 mouse myeloma tumor and a variant spleen clone. Baumal R; Scharff MD J Immunol; 1976 Jan; 116(1):65-74. PubMed ID: 812916 [TBL] [Abstract][Full Text] [Related]
17. Mouse myeloma cells that make short immunoglobulin heavy chains: pleiotropic effects on glycosylation and chain assembly. Kenter AL; Warren T; Shields D; Birshtein BK J Cell Biol; 1984 Jun; 98(6):2215-21. PubMed ID: 6427235 [TBL] [Abstract][Full Text] [Related]
18. Alteration of immunoglobulin phenotype in cell culture-adapted lines of two mouse plasmacytomas. Hausman SJ; Bosma MJ J Exp Med; 1975 Oct; 142(4):998-1010. PubMed ID: 51902 [TBL] [Abstract][Full Text] [Related]
19. Analysis of immunoglobulin mRNA in murine myeloma cell variants defective in the synthesis of the light or heavy polypeptide chains. Wallach M; Ishay-Michaeli R; Givol D; Laskov R J Immunol; 1982 Feb; 128(2):684-90. PubMed ID: 6798120 [No Abstract] [Full Text] [Related]
20. Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NP-1, a variant synthesizing only heavy chain. Green M; McInnes J; Graves PN; Jilka R; Yaffe L; Bailey LK; Pestka S Arch Biochem Biophys; 1977 Nov; 184(1):87-94. PubMed ID: 411424 [No Abstract] [Full Text] [Related] [Next] [New Search]